fda approved indications for semaglutide Oral Wegovy obesity management by on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) What are the FDA approval

One Mayo Clinic forum discussion acknowledged that an alternating 6-month approach is "creative" and might allow you to get benefits from both while minimizing cumulative side effects

The decision to increase depends on your rate of weight loss, your tolerance profile, and how far you are from your goal

The degradation curve at room temperature Room temperature exposure is the most common storage mistake

Rani, R

Melamed says its important for the prescriber to consider titrating the new GLP-1 agonist from a lower dose. In other words, your healthcare provider may start Ozempic at the lowest dose, then increase it gradually to match the equivalent of your previous compounded semaglutide dose

He stressed the importance of changing my habits or the weight would come right back once I stopped taking GLP-1 medication